Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Treatment of upper airway diseases in patients with cystic fibrosis

Шумкова Г. Л., Амелина Е. Л., Свистушкин В. М., Красовскиy С. А., Каширскайа Н. Y., Син’ков Е. В.
Пульмонология
Т. 28, Вып. 6, С. 754-761
Опубликовано: 2018
Тип ресурса: Статья

DOI:10.18093/0869-0189-2018-28-6-754-761

Аннотация:
Chronic rhinosinusitis with nasal polyps (CRS NP) is the most prevalent ear, nose, and throat (ENT) disorder in cystic fibrosis (CF) patients. CRS NP can occur in CF children at the age of ≥ 8 months and becomes the chronic disease. Tenacious secret and bacterial infection cause obstruction, edema and hypoxia of paranasal sinuses and contribute to significant morbidity in CF patients. The active monitoring and treatment of CRS NP aimed at improvement of the aeration of paranasal sinuses, mucociliary clearance, and the control of chronic upper airway infection are necessary. Functional Endoscopic Sinus Surgery (FESS) may be the method of choice if surgical treatment is considered. FESS facilitates paranasal sinuses drainage. Due to recurrent course of CRS NP in most CF patients, lifelong follow-up by an ENT specialist and postoperative management using topical steroids and/or antibiotics are required. © 2018 Medical Education. All Rights Reserved.
Ключевые слова:
Cystic fibrosis; Inhalational therapy; Nasal polyps; Purulent rhinosinusitis; Sinusotomy
antibiotic agent; steroid; Article; bacterial infection; chronic rhinosinusitis; cystic fibrosis; endoscopic sinus surgery; follow up; human; morbidity; mucociliary clearance; nose polyp; paranasal sinus; upper respiratory tract infection
Язык текста: Русский
ISSN: 0869-0189
Шумкова Г. Л. Галина Леонидовна 1981-
Амелина Е. Л.
Свистушкин В. М. Валерий Михайлович 1960-
Красовскиy С. А.
Каширскайа Н. Y. Н.Ю.
Син’ков Е. В.
Shumkova G. L. Galina Leonidovna 1981-
Amelina E. L.
Svistushkin V. M. Valerij Mikhaylovich 1960-
Krasovskiy S. A.
Kashirskaya N. Y. N.Yu.
Sin’kov E. V.
Treatment of upper airway diseases in patients with cystic fibrosis
Текст визуальный непосредственный
Пульмонология
Научно-практический журнал "Пульмонология"
Т. 28, Вып. 6 С. 754-761
2018
Статья
Cystic fibrosis Inhalational therapy Nasal polyps Purulent rhinosinusitis Sinusotomy
antibiotic agent steroid Article bacterial infection chronic rhinosinusitis cystic fibrosis endoscopic sinus surgery follow up human morbidity mucociliary clearance nose polyp paranasal sinus upper respiratory tract infection
Chronic rhinosinusitis with nasal polyps (CRS NP) is the most prevalent ear, nose, and throat (ENT) disorder in cystic fibrosis (CF) patients. CRS NP can occur in CF children at the age of ≥ 8 months and becomes the chronic disease. Tenacious secret and bacterial infection cause obstruction, edema and hypoxia of paranasal sinuses and contribute to significant morbidity in CF patients. The active monitoring and treatment of CRS NP aimed at improvement of the aeration of paranasal sinuses, mucociliary clearance, and the control of chronic upper airway infection are necessary. Functional Endoscopic Sinus Surgery (FESS) may be the method of choice if surgical treatment is considered. FESS facilitates paranasal sinuses drainage. Due to recurrent course of CRS NP in most CF patients, lifelong follow-up by an ENT specialist and postoperative management using topical steroids and/or antibiotics are required. © 2018 Medical Education. All Rights Reserved.